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Abstract 
 
The effect of flavonoid-rich food, such as blueberries, on cognitive function has been subject to a 
growing amount of research interest in recent years. Epidemiological, prospective, pre-clinical and 
clinical trials have revealed positive cognitive benefits from flavonoid interventions, particularly in 
relation to the amelioration of cognitive decline in older adults. This review will specifically consider 
the existing clinical research from both acute and chronic blueberry interventions on cognition in 
human subjects. The results of 11 studies are reported with four studies considering blueberry 
intervention with 7 – 10 yr old children, four considering aging 60+ yr old adults, and three 
considering adults suffering from mild cognitive impairment (MCI). Findings from these studies 
indicate that cognitive benefits may be found for delayed memory and executive function in children 
and for delayed memory, executive function, and psychomotor function in older healthy and MCI 
adults. There is less evidence to suggest positive benefits of blueberry intervention on working 
memory. Recommendations for future research including dose used, cognitive tasks, and age groups 
considered, are proposed.  
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Introduction 
Blueberries have been the subject of a number of health-related research studies in recent years 
with supplementation showing reduced risks for metabolic syndrome, cancer, cardiovascular disease 
and also cognitive decline (1). Mechanistically, initial research (2, 3) focused on the anti-oxidant 
properties of flavonoids and their ability to combat oxidative stress (OS). However, recent studies 
have suggested a number of other mechanisms by which flavonoid-rich interventions may promote 
cognitive health (for a review see (4)). Indeed, recent mechanistic research has shown that the 
health benefits of blueberries may be ascribed to their particularly high flavonoid content. As can be 
seen from table 1, blueberries are particularly high in anthocyanins along with lower amounts of 
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flavanols and flavonols, all of which are flavonoid subclasses (5). They also contain small quantities 
of phenolic acids, in particular chlorogenic acid (5). Although there is evidence of higher anthocyanin 
content in other berries such as chokeberries, the ease of blueberry availability and also their 
relatively better palatability make them ideal candidates for flavonoid-rich intervention studies. 
Previous studies have documented that lowbush (typically called ‘wild’) and highbush blueberry 
varieties differ in taste, size and flavonoid content. Lowbush blueberries tend to be smaller, have a 
more intense flavour, and are usually found growing wild in colder and harsher climates whilst high-
bush blueberries tend to be bigger and grow in abundance. For this reason, highbush blueberries 
tend to be the first choice for commercial cultivation, however high performance liquid 
chromatography-mass spectrometry (HPLC-MS) has revealed that the lowbush variety contains 
approximately three times the amount of phenolic compounds found in highbush varieties (6, 7). 
Many different factors could account for these differences; such as cultivar, cultivation practise, 
environmental growing conditions, processing and storage (8-11).  
 
Table 1 here
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In recent years, blueberries have gained significant attention for their ability to promote better 
cognitive performance and also contribute to a delay in cognitive decline as we age. Epidemiological 
studies suggest that intake of flavonoid-rich foods, such as blueberries, ameliorates cognitive decline 
during ageing. For example, Letenneur et al. (12) investigated the effects of flavonoid consumption 
in a group of 1640 older adults aged 65+ over a 10-year period finding better cognitive performance 
in participants who consumed greater amounts of dietary flavonoids. Similarly, the Nurses’ health 
study (13) monitored cognition and dietary intake over 20 years in a cohort of 16,010 women, aged 
70 or above, finding increased consumption of blueberries was related to slower cognitive decline. 
Both studies support the notion that flavonoids not only have a beneficial effect on cognition during 
aging, but also may offer neuroprotective properties.  
In addition to this epidemiological data, various pre-clinical animal studies have been conducted to 
investigate the effects of flavonoids derived from berries on cognition. In one of the first studies of 
its kind, Joseph et al. (14) found blueberry, strawberry, or spinach supplementation for 8 weeks in 
mice with neurodegeneration resulted in a reversal of neuronal ageing which they attributed to a 
reduction oxidative stress damage. Whilst this was one of the first studies to document a potential 
mechanism of action for positive cognitive effects following blueberry supplementation, as outlined 
above, other possible mechanisms have also been described in recent years including the flavonoid-
induced upregulation of neuronal signalling proteins. For example, work from our lab (15) found that 
18-month old rats supplemented for 12 weeks with blueberry showed elevated hippocampal levels 
of cAMP-response element-binding protein (CREB), extracellular signal-related kinase ERK1/2, and 
brain-derived neurotrophic factor (BDNF) in comparison to age-matched controls. Importantly, the 
alteration in these signalling proteins was accompanied by better performance on a spatial working 
memory cross maze task. In a follow-up study, we demonstrated that the beneficial effects of 
blueberry supplementation could also be found on spatial working-memory tasks in younger rats 
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aged 2 months, again accompanied by increased hippocampal levels of BDNF, CREB and ERK1/2 
activation (16). BDNF seems to be a particularly important potential mechanism of action for 
blueberry supplementation. In humans BDNF levels are known to decrease across the day (17, 18) 
however, research by Dodd (19) has found that, in both younger (18 – 25 yrs) and older (62 – 73 yrs) 
adults, plasma levels of BDNF are maintained following blueberry intervention compared to placebo 
treatments where levels decrease. Furthermore, BDNF is thought to play a critical role in the delay of 
ageing by improving hippocampal plasticity as well as increasing neurogenesis and long-term 
memory (20). Therefore, these pre-clinical studies (17, 18) and the findings by Dodd (19) suggest a 
possible mechanism of action whereby blueberry intervention contributes to the maintenance of 
BDNF availability which may be critical for cognitive function. Pre-clinical studies have also provided 
evidence that blueberry flavonoids may exert a positive effect on neuroinflammation. For example, 
Shukitt-Hale et al. (21) found that, following infusion of kainic acid (KA) to the hippocampus, 4-
month-old rats supplemented with blueberry performed better on a Morris water maze task and 
showed a reduced inflammatory response to the KA insult. Finally, Casadesus et al. (22) found that, 
when compared to placebo group, there was increased hippocampal neurogenesis alongside 
improved spatial memory performance in aged rats following 8 weeks blueberry supplementation.  
Taken as whole there are a number of possible mechanisms underpinning the beneficial cognitive 
effects of blueberry intervention, these include antioxidant and anti-inflammatory actions, up-
regulation of neuronal signalling proteins, and stimulation of neurogenesis. Further details of pre-
clinical studies which have considered the potential mechanisms of action underpinning blueberry 
intervention can be found in reviews by Miller et al. (23), and Pribis and Shukitt-Hale (24). However, 
evidence would suggest that, irrespective of mechanism of action, the positive effects of blueberry 
intervention can be found primarily in the hippocampus, a brain area critical for optimal memory 
function (15, 22, 25, 26). 
7 
 
From the pre-clinical research described above, there is good evidence from both a mechanistic and 
behavioural level to suggest that blueberry intervention should facilitate improved cognitive 
performance in clinical trials. Therefore, this review will assess the evidence from both acute and 
chronic intervention studies for the beneficial effects of blueberry on human cognitive functioning 
across the lifespan. The domains of cognitive function found to be sensitive to blueberry 
interventions will be identified and, based on the reported research, cognitive areas which have yet 
to be considered will be highlighted. Tentative recommendations regarding future research 
directions will also be made. 
 
Method 
An electronic search of PubMed, Google Scholar and Web of Science was conducted using the search 
terms Blueberr* and/or Berr*, Anthocyan* and/or Flavonoid*, Cognit* and/or Polyphenol* and/or 
Memory and Executive function. The studies selected for inclusion were all subject to peer- and/or 
editorial-review, and for this reason, conference abstracts have been omitted. Papers published in 
the English language, with no restriction on publication date, were selected, and subsequently the 
bibliography of each paper was scanned to reveal further possible papers.  The following inclusion 
and exclusion criteria were implemented:  
 Inclusion: Human studies, participants of all ages, healthy participants/participants with MCI, 
studies measuring the effect of blueberries on cognitive function, cognition measured using 
appropriate cognitive tasks, all forms of blueberry treatment including juice, fresh, powder, 
extract, and smoothie.  
 Exclusion criteria: Epidemiological studies, participants with neurodegenerative diseases 
such as Alzheimer’s, animal studies, studies using more than just blueberries e.g mixed berry 
drink.  
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Results 
In total, 11 studies considering the cognitive effects of blueberry intervention were found 
(summarised in Tables 2-4). The primary cognitive domains considered were episodic memory (EM), 
working memory (WM), executive function (EF), and psychomotor function (PF), although a wide 
range of different tasks were used to test these cognitive domains (Note: detailed descriptions of 
the tasks used can be found in Supplementary information). No studies were found considering the 
effect of blueberry interventions on young or middle aged adults with the research to date focusing 
exclusively on children aged 7 – 10, healthy older adults aged 60+, or older adults exhibiting 
symptoms of Mild Cognitive Impairment (MCI).  
The effects of blueberry polyphenols in children 
Four studies have investigated the effect of blueberry interventions on the cognitive function of 
children aged between 7 – 10 years of age (Table 2). All four of the studies considered the acute 
effects of blueberry intervention and, to date, no published studies have considered chronic 
repeated administration designs.  
The first study considering the acute effects of blueberry intervention on children was performed by 
Whyte and Williams (27). In this crossover trial, a blueberry-based drink was administered to a group 
of 14 children aged 8-10 years old. The drink consisted of 200g fresh highbush blueberries, blended 
with milk, giving a reported total anthocyanin concentration of 143 mg.  This was a randomised 
crossover study design, with a 7-day washout period between the two study days. Baseline testing 
was not employed in this study but instead, on each study day, the cognition of each child was 
tested at 2 hours post consumption of either the blueberry or placebo drink. The cognitive tasks 
used in this study included the Go-NoGo, Stroop, Auditory Verbal Learning Task (AVLT), Object 
Location Task, and Visual N-back.  
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The study yielded no significant effects for accuracy and reaction times (RT) of blueberry 
intervention on any of the outcome measures in the Go-NoGo, Stroop, N-back or the object location 
task. However, ANOVA analysis of the AVLT revealed a significant benefit of blueberry, in 
comparison to placebo, for the main effect across short and long delayed word recall. Further post-
hoc analysis revealed a positive trend for better recall following blueberry after a 25-minute delay 
indicating a sensitivity to delayed recall following blueberry intervention in children. In terms of 
proactive interference (PI) there was evidence that performance was less affected following the 
placebo drink compared to blueberry. However, when the interference recall list performance was 
directly compared no significant difference was found leading the authors to conclude that this 
effect was more likely an artefact of the PI calculation when applied across two separate test 
sessions.  
In a follow-up RCT within subjects study, Whyte et al. (28) considered the effects of two wild 
blueberry interventions of 15 and 30g (anthocyanin content of 127mg and 253mg respectively), or 
matched placebo on cognitive performance in 7 – 10 yr old children. On each study day cognitive 
tests were performed at baseline, then 1.5, 3, and 6 hrs following intervention. The four cognitive 
tasks used were the AVLT (as above), Modified flanker Task (MFT), Go-NoGo (as above), and Picture 
Matching Task (PMT). Analysis revealed dose response effects for both memory and EF measures. 
Memory effects included a significant interaction for the AVLT measure of final acquisition of the 
word list, with post-hoc analysis revealing significantly better 30-g WBB performance at 1.5 hrs in 
comparison to placebo. Additionally, for delayed word recognition, although there was a decrease in 
performance across the test day for all three treatments, there was a significant main effect of dose 
with the placebo performing least well overall. Furthermore, post-hoc analysis revealed the 
difference between placebo vs 15-g WBB and between placebo vs 30-g WBB to be greatest at the 
6hr time point. Executive function effects included a significant effect 3hrs after the intervention on 
the incongruent trials of the flanker task where, compared to baseline performance, 30-g WBB 
performance improved, placebo performance deteriorated, and there was no change for the 15-g 
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treatment.  Analysis of the data also revealed significant linear trends for Final Acquisition, Word 
Recognition, Incongruent MANT trials, and Picture Name Matching Trials, with the placebo 
performing least well, followed by the 15-g WBB and then the 30-g WBB performing best in all cases. 
Given this evidence of a dose response effect, a non-parametric Page’s test was conducted on 
combined scores from all tasks and session revealing a monotonic increase in cognitive performance 
in relation to WBB dose. 
A more recent study by Whyte et al. (29) focused on the cognitive effects of a 30g WBB treatment 
(containing 253 mg anthocyanins) coinciding with the 3-hr point at which positive cognitive EF 
effects were found in the previous Whyte et al. (28) paper. The aims of the study were to explore 
the effects of varying demand on cognitive performance following a flavonoid rich WBB 
intervention. This study employed the Modified Attention Network Task (MANT), an executive 
function task that can be manipulated to vary cognitive demand/load across a number of different 
factors such as congruency, visual load, distractor noise, target duration, and target cueing. The 
results revealed that following WBB intervention, there was a significant global effect whereby 
children responded to the stimuli significantly faster, compared to placebo. Furthermore, it was 
found that WBB cognitive performance was better in comparison to placebo at the slower 500ms 
presentation rate during the more cognitively demanding, high visual load incongruent trails, 
supporting the study’s hypothesis. However, cues alerting the appearance of the target also 
facilitated significantly better WBB performance in comparison to placebo. In contrast to the earlier 
findings of Whyte et al. (28), no effects on accuracy were found for this EF task.  
Barfoot et al (30) looked at the acute effects (2 hrs) of blueberries on executive function using the 
MANT on a group of 54 children aged 7-10. In this study they employed a single-blind, parallel-
groups design. As well as executive function, they tested the effect on verbal memory using AVLT 
and reading efficiency using Test of Word Reading Efficiency-2 (TOWRE-2). Mirroring the findings of 
Whyte et al. (28) executive function benefits were found with significantly faster reaction times on 
11 
 
the MANT following WBB treatment, although on this occasion, the benefits were found on the trials 
presented at the faster 120 ms rate with no loss in accuracy. Furthermore, similar to the AVLT final 
acquisition and delayed recall benefits found by Whyte et al. (28), total acquisition performance was 
improved following the blueberry intervention, with significant improvements seen on the short 
delay trials. There were no effects seen for any of the TOWRE-2 parameters.  
In summary, four studies have considered the impact of blueberry interventions on cognitive 
performance in children (however see Khalid et al. (31) for positive effects on a measure of mood). 
These studies have found evidence that executive function and delayed memory performance are 
positively affected by blueberry treatment in comparison to placebo. It should be noted that, to 
date, only a narrow age range, between 7 – 10 yrs has been considered with effects in infants and 
teenagers yet to be explored.  
Table 2 here 
The effects of blueberry polyphenols in healthy older adults. 
Four studies have been conducted looking at the effects of blueberry on cognition in healthy older 
adults. This research is in line with a wider and growing body of research considering the delay of 
cognitive decline in older adults (32-34). Previous findings from pre-clinical experiments looking at 
the effects of blueberry on the cognition of aged animals showed a positive change in working 
memory performance as well as improved mobility in aged rats (14, 25). Building on these findings, 
Miller et al. (35) considered the effect of a 24g freeze dried blueberry (19.2 mg/g anthocyanins, 
equivalent to 460 mg anthocyanins daily) intervention on the cognitive performance and mobility of 
adults aged 60-75 years old for a total of three months (n=37). The study consisted of a parallel 
design, and measurements were taken at day 1, day 45, and day 90. Note, for the purpose this 
review, only cognitive outcomes will be discussed. The cognitive tasks included in this study were the 
Task-switching test (TST), Trail making test (TMT), California Verbal Learning Test (CVLT), Digit span 
(DS) task, a virtual version of the Morris Water Maze (vMWM), and Attention Network Task (ANT). 
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Results for TST generated no significant differences between treatments for reaction times. In terms 
of accuracy, a reduction in switch cost was indicated whereby there was a significant visit by 
treatment interaction with participants in the blueberry condition showing a reduction in switch trial 
errors over the test visits in comparison to placebo. In the CVLT, participants improved significantly 
on the number of words correctly recalled regardless of treatment. However, there was a significant 
visit by treatment interaction with participants in the blueberry group making fewer repetition 
errors on day 90 than they did on day 0. Participants in the placebo group showed the opposite 
pattern making more repetition errors at day 90. There were no significant treatment related effects 
of blueberry on any of the other stated outcomes measures.   
              Schrager, Hilton, Gould and Kelly (36) considered the positive effects of blueberry intervention on 
motor and psychomotor function along with tests of executive function. Twenty unblinded 
participants were randomly allocated to either a daily regimen of 2 cups of blueberries (n = 13) or a 
carrot juice placebo (n = 7) for 6 weeks. The polyphenol and anthocyanin content of the blueberry 
intervention were not stated. The cognitive tasks used were the Simple Reaction Time, TMT B, and 
Dual-Task adaptive gait test (DTAG). Further measures of grip strength, gait speed and adaptive gait 
were also recorded. Analysis of the results revealed a significant improvement in executive function 
following blueberry treatment with participants performing less step errors during the DTAG in 
comparison to the placebo condition. There were no other treatment related effects for the 
cognitive tasks in this study, however the participants also showed improved motor function related 
to increased gait speed following blueberry intervention. It should be noted that there are possible 
issues with the control drink used in this study. Although not a rich source of flavonoids, carrots are 
abundant in carotenoids and other polyphenolic compounds. Research has shown that the 
carotenoids, lutein and zeaxanthin, are associated with improved cognitive function (37, 38) whilst 
long-term supplementation with beta-carotene influences cognition (39). Besides these issues with 
components in the placebo treatment that are known to influence cognition themselves, 
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participants were also unblinded to the treatment they received. Given these concerns over the 
design, some caution should be employed in consideration of the findings here. 
Bowtell et al. (40) looked at the effects of blueberry supplementation on cerebral blood flow, with 
cognition as a secondary outcome. The study adopted a parallel, double blind design, testing the 
effects in 26 healthy adults, with an average age of 68 yrs, after 12 weeks of supplementation. The 
cognitive battery consisted of 6 tasks: 1) Detection task, 2) Groton maze timed chase test, 3) Groton 
maze learning test, 4) Identification task, 5) International shopping list task, and 6) 1-back and 2-back 
task.  To measure brain activation, functional magnetic resonance imaging (fMRI) was performed 
whilst the participants conducted a numerical Stroop task. Arterial spin labelling (ASL) measures of 
brain perfusion were also gathered whilst the participant was in a rested state. Analysis revealed no 
significant treatment-related effects on the Detection Task, Groton Maze tests, Identification task, 
shopping list task, and Stroop test, however, there was a trend towards better performance in the 1-
back test and trends for improved reaction time and accuracy on the 2-back test. Although there 
were no significant treatment-related behavioural effects whilst performing the response 
interference Stroop task, fMRI analysis revealed significant increases in activation of a number of 
task related areas (Brodman areas 4, 6, 10, 21, 40, 44, 45, precuneus, anterior cingulate, insula, and 
thalamus) in comparison to baseline. No such effects were found for the placebo. Furthermore, the 
resting state ASL analysis revealed increased grey matter perfusion in the parietal and occipital lobes 
following blueberry whereas, again, no effect was found for the placebo.   
A recent study by Whyte et al. (41) compared three blueberry treatments stabilised with L-cysteine 
and L-Glutathione with placebo on measures of cognitive function, cardiovascular function and 
mood. A total of 112 healthy, older participants completed the 6-month long study consuming two 
capsules of their allocated treatment per day, with testing occurring at baseline, 3 months and 6 
months. The participants were randomised into 4 treatment groups consisting of placebo, 500 mg 
wild blueberry powder (WBB), 1000 mg WBB, and 111 mg wild blueberry extract (WBE) containing 0, 
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1.35, 2.7 and 7 mg anthocyanin content and 0, 35, 70 and 50 mg polyphenols, respectively. Although 
the anthocyanin content is lower than what would be present from a single serving of fresh 
blueberries, all treatments had L-cysteine and L-Glutathione added to them in order to facilitate the 
stabilisation of their anthocyanin content and, in turn, allow a higher rate of absorption than might 
be possible via general habitual intake or at doses used in previous studies. In terms of cognitive 
testing, the primary outcome measure was episodic memory, via three different tasks including the 
RAVLT, object recognition task, and Corsi Block task. The secondary cognitive outcome measures 
tested executive function, attention and working memory. Tasks included the Serial 3’s and 7’s, 
Sternberg memory scanning task, MANT, and Stroop task.  
Linear mixed model analysis revealed that for the word recognition measure of the AVLT, there was 
a significant treatment by time interaction with post hoc analysis finding improvement after 
supplementation with WBE compared to the placebo after 3 months, but not after 6 months. There 
were no significant differences for the other blueberry treatments for this measure. A similar pattern 
of results was found for the total number of Corsi Block sequences correctly recalled where there 
was a significant treatment by time interaction with post hoc analysis finding a trend for 
improvement following supplementation with WBE compared to the placebo after 3 months, but 
not after 6 months. Again, there were no significant differences for the other blueberry treatments 
for this measure.  For the working memory and executive function tasks, there were no significant 
effects for any of the blueberry treatment compared to placebo at any of the time points. In terms 
of the markers of cardiovascular health, a main effect of intervention was found with post-hoc 
analysis revealing significantly lower WBE systolic blood pressure over the 6-month intervention, 
however, no such effect was found for the other blueberry treatments. It is interesting, and 
somewhat unexpected, that no significant differences in cognitive performance were seen after 6 
months and the authors posit that this may reflect an element of practice whereby participants 
improved their strategy to perform these tasks over time with repeated exposure thus reducing task 
sensitivity to the intervention.  
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In summary, four studies have investigated the effects of pure blueberry intervention in older adults. 
Results from these studies have been mixed. Of the three studies which considered episodic 
memory, only two (35, 41) found significant effects in the different subdomains of delayed 
recognition and repetition errors. All studies considered executive function, though positive 
behavioural benefits were only found in two. It could, however, be argued that the effects were 
found on the more cognitively demanding switch trials of the switching task (35) and the Dual Task 
Adaptive Gait Test (36). Furthermore, the elevated brain activation, which was found in the absence 
of significant behavioural effects during performance of the less cognitively demanding Stroop task 
(40), gives further indication that in order to establish blueberry related executive function benefits 
within an older age group, the level of task demand should be carefully considered.  
Table 3 here 
Adults with mild cognitive impairment 
Similarly to the other age groupings assessed in this review, there are few studies considering the 
effects of blueberry supplementation in adults with mild cognitive impairment. To date, only 3 
studies fulfilled our inclusion and exclusion criteria.  
Krikorian et al. (33) investigated for the first time the effects of blueberry on cognition on older 
adults with MCI. The sample size was a total of 9 participants with a mean age ±72 along with the 
data from a placebo group of 7 participants gathered from a previous Concord grape juice study 
(42). The study employed a randomised, double blind, placebo-controlled trial testing the effects of 
blueberry for 12 weeks. Dosage of blueberry treatment was calculated according to body weight, 
more specifically, participants weighing 54-64kg received 444 mL/day and participants in 65-76 kg 
received 532 mL/day, participants weighing 77-91 kg received 621 mL/day, the placebo was a grape-
flavoured drink that contained no polyphenols.  Cognitive measurements from both treatment 
groups were taken at baseline and 12 weeks and the participants performed a battery consisting of 
two tasks testing verbal learning and memory which are known to be processed by the hippocampal 
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region. The tasks included Verbal Paired Associate Learning Test (V-PAL) and the California Verbal 
Learning Test (CVLT).  
Analysis of the V-PAL cumulative learning scores showed the cumulative score significantly improved 
at 12 weeks compared to baseline, as did delayed recall performance during the CVLT. However, no 
mention is made regarding these comparisons for the placebo either in this paper or the companion 
study from which the placebo group data was drawn. This raises the possibility that the findings 
were primarily practice effects. Acknowledging this possibility Krikorian et al. performed a further 
comparison with the placebo group on the 12-week time point data which found significantly better 
V-PAL performance for those receiving the blueberry intervention, however no such effect was 
found for the CVLT data. This would indicate that whilst the V-PAL effects would seem to be robust, 
the effects reported for the CVLT should be considered with caution.  Furthermore, although the 
results yielded significant effects, this was a small study (n=16 which includes data from a placebo 
group from a different study).  
Boespflug et al. (32) measured working memory performance in a group of MCI participants aged 
68-92 (n=16). Additionally, brain activation was assessed using fMRI whilst the participants 
conducted a cognitive task. The study employed a randomized, double-blind, placebo-controlled 
parallel study. The cognitive task used was the sequential letter n-back, assessing working memory, 
as in Bowtell et al. (40). In this study, there were three different conditions; 0-back, 1-back, 2-back 
with the outcome measures being accuracy and reaction time. The treatment was administered as a 
drink consisting of water and blueberry powder giving a daily dosage of 269 mg of anthocyanins, 
equivalent to roughly 220g of fresh blueberries. This was administered daily for a total of 4 months, 
with measurements taken at pre-intervention (baseline) and post-intervention (week 16).  
Analysis of working memory performance revealed that for all the 0-back and 2-back conditions 
there were no significant improvements in reaction time at any of the timepoints. For the 1-back 
condition, there was a trend towards significance (p = .08) for accuracy in the blueberry group 
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compared placebo group performance at 16 weeks. However, though a significant difference was 
found at baseline, with placebo performing significantly faster than blueberry in the 1-back 
condition, no reaction time differences were found between treatments post-intervention. In terms 
of fMRI results, there were observed changes in the blueberry treated group, with increased 
activation in the left pre-central gyrus, left middle frontal gyrus, and left inferior parietal lobe during 
the final visit (16 weeks). More specifically, analysis revealed a significant increase of signalling in the 
left inferior parietal gyrus and left pre-central gyrus during the 2-back condition for blueberry 
treated group. There were, however, no significant effects of activation under the 0-back and 1-back 
conditions. In terms of the placebo group, decreased activation was witnessed close to the left post-
central gyrus at the final visit compared to baseline.   
A more recent study by McNamara et al. (34) investigated the effects of blueberry supplementation, 
fish oil, and a combination of the two on the cognition of 94 healthy men and women aged between 
62-80 years old who had not been diagnosed with any form of cognitive impairments, but did suffer 
from self-reported cognitive complaints. The sample population was divided into four groups; 
blueberry powder + placebo oil; fish oil + placebo powder; blueberry powder + fish oil; and placebo 
powder + placebo oil. The blueberry treatment was equivalent to 25g dry weight of blueberry a day 
and provided 269 mg of anthocyanins per serving. The intervention lasted a period of 24 weeks with 
measurements taking place at week 0 (baseline) and week 24, as well as an additional measurement 
24 weeks after the intervention period (week 48). A total of 76 participants completed the whole 
study successfully and a total of 65 took part in the post-intervention measurements. Cognitive 
assessments used included Dysexecutive Questionnaire (DEX) to assess executive function, Trail 
making tests A and B (TMT-A and TMT-B), Controlled Oral Word Production, and Hopkins Verbal 
Learning Test (HVLT) to assess verbal learning and long-term memory. As well as cognition, there 
were measurements of red blood cell fatty acid composition, anthocyanin levels in urine, metabolic 
factors, APOE genotyping as well as anthropometrics measurements. In the context of this review, 
only the cognitive outcomes will be discussed. 
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Results found that for the DEX, the scores for the blueberry treated group decreased significantly, 
indicating that fewer negative cognitive symptoms experienced in everyday activities at 24 weeks. 
This benefit was maintained at the 48 week point, 24 weeks following the cessation of treatment.  
Furthermore, the blueberry treated group displayed improvements in HVLT recognition memory 
discrimination performance after 24 weeks, however, this effect was not maintained at 48 weeks. 
There were no significant blueberry-related improvements for any of the other tasks. Comparing this 
with the other interventions, the DEX scores also decreased significantly for the fish oil-treated 
group whilst increases on DEX were seen following placebo. As for the other cognitive tasks, no 
significant improvements were observed for either fish oil, the combined fish oil and blueberry 
group, or the placebo groups. Overall, the researchers concluded that, in a sample of older adults 
experiencing self-diagnosed cognitive complaints, the blueberry intervention improved cognitive 
efficiency for everyday life activities, as well as improving resilience against extraneous disturbances 
during a recognition memory task.  
Of the two studies above which considered episodic memory, both found positive effects following 
blueberry intervention. Interestingly, the recognition memory performance found in healthy adults 
by Whyte et al. (28) was also found by McNamara et al.(34) in adults suffering from mild cognitive 
complaints, indicating the sensitivity of this measure to blueberry intervention in an aging 
population. There was little evidence of a working memory effect, with the results of Boespflug et 
al.(32) only trending towards significance, however, in a similar fashion to Bowtell et al. (40) fMRI 
analysis again showed elevated task related brain activation despite no behavioural effects being 
found.  
Table 4 here 
Discussion 
Studies investigating the effects of blueberry intervention to date have been limited and have only 
considered two main age groups, children aged between 7 – 10 years old or older adults aged 60 and 
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above. This latter group can be further subdivided in to healthy adults and those with MCI. As 
regards study type, only acute (single administration) interventions have been published with 
children whilst only chronic (repeated administration) interventions using varying durations of 
treatment have been published with older adults. Tasks employed have differed between studies 
with some considering only one cognitive domain and others a wider range. Furthermore, 
anthocyanin doses employed have ranged from 1.35 mg to 460 mg in chronic studies and between 
143 mg and 253 mg in acute studies. Cognitive results from these studies have been mixed, with 
results not being seen consistently across the different domains considered, though see below for 
comments on task sensitivity. Furthermore, as can be seen from Tables 2-4, there was a spread of 
effect sizes with Cohen’s d ranging between .175 and 1.94. Making any strong conclusions regarding 
expected cognitive outcomes in relation to developmental stages and proposing best practice for 
future research is therefore not possible given the literature available. The following discussion 
should therefore be considered in this light.  
Within the domain of memory, benefits have primarily been found on episodic measures with 
significant improvements being found for acute child interventions on the AVLT in word acquisition, 
delayed recall, and word recognition (27, 28, 30). Interestingly the effect of improved episodic 
memory performance is also seen in chronic older adult interventions with a number of studies 
finding positive effects on either the CVLT, HVLT, or AVLT measures of episodic memory (). It should 
be noted that the above studies were the only ones to include measures of episodic memory in the 
task batteries used and, in all cases, at least one sub-domain was positively affected by intervention. 
This gives some indication that episodic memory is particularly sensitive to anthocyanin blueberry 
intervention in both children and older adults. It should be noted however that, in a review of the 
literature considering acute flavonoid interventions of all classes, Bell et al. ((43)) reported there was 
little evidence of a positive episodic memory effect in young adults and further blueberry related 
research is therefore required to clarify whether episodic memory effects might also be found within 
this age group.    
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The positive benefits of executive function (EF) are also present in the literature for both age groups 
with children showing improved performance following blueberry intervention on the more 
cognitively demanding response interference trials of the modified flanker and modified attention 
network tasks (28, 29). In older adults the results are more equivocal with only two out of the four 
studies which measured EF reporting blueberry related effects. It should be noted that where there 
were significant findings, the effects were found on arguably the more cognitively demanding 
elements of the tasks with results being found on the critical switch trials of the switching task (35), 
and the dual task adaptive gait task involving the simultaneous performance of two tasks at once 
(36). When considered together, the results of both the acute and chronic studies indicate that 
blueberry intervention may have an effect on EF, however, task sensitivity is critical with the 
improvements becoming more evident between treatment and placebo as the cognitive demand of 
the task increases. This highlights the importance of task sensitivity and demonstrated that some 
tasks used in the studies presented in this review may not have been sufficiently demanding for 
differences in performance to be observed between treatment groups. 
Tests of working memory have revealed no evidence of blueberry related benefits in children (27, 
28). For older adults benefits of WM were found in two of the four studies which considered this 
domain with the effects being seen either on 1 or 2 n back tasks (32, 40) however, it should be noted 
that these effects were trends and, in both studies, there was no reported statistical correction for 
the analysis of the multiple n-back versions employed. Taken as a whole, therefore, the literature 
would suggest there is little benefit to be found for blueberry intervention within this domain.  
One explanation for the benefits found in cognitive function could be due to improved memory 
encoding as a result of elevated levels of BDNF. Pre-clinical studies have shown blueberry’s efficacy 
in increasing the level of brain-derived neurotrophic factor (BDNF) in the hippocampal area of the 
brain (15, 16). BDNF is a neurotrophin, a protein that plays an important role in cell regeneration, 
differentiation, survival and death of neurons (44). Emerging evidence suggests that BDNF plays a 
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significant role in memory, and that BDNF declines as we grow older; this is believed to be one 
reason why memory loss and cognitive decline is often a frequent effect of ageing (45). Moreover, 
studies have shown that the activation of cAMP-response element-binding protein (CREB), a 
transcription factor that plays an important role in the formation of long-term memory (46) is 
positively correlated with an increase in memory after supplementation with blueberry polyphenols 
in aged rats (15) and an increase in spatial memory in young rats (16). It is also believed that 
increased cognition could be due to increased neurogenesis. Studies in animals have shown that 
neuron proliferation increased after blueberry supplementation (22). Recent fMRI studies have 
shown an increase in cerebral blood flow after supplementation with berry polyphenols, particularly 
in the parietal lobe and occipital lobe(32, 40). One effect of increased cerebral blood flow is an 
increase of oxygen and glucose to neurons, which may enhance neuronal activity.  
Factors such as time-point, dosage, administration form, and choice of cognitive tasks need to be 
taken into consideration before recommendations can be made for future research. From the acute 
studies looking at time-response effects in children, it seems that there are different responses 
being produced at different times. For example, results have shown delayed memory performance is 
best performed 1.15 hours post consumption (28), whereas improvements in executive function 
performance is seen at 3 hrs (28, 29). The time point differences observed could be due to factors 
such as absorption rate, digestion, and breakdown of metabolites (43) although further testing is 
necessary in order to understand these mechanisms.  
For chronic studies there was one case where cognitive effects for word recognition were observed 
at the intermediate testing point of 12 weeks  but not at the final testing point of 48 weeks (41). This 
raises questions related to the metabolism and absorption of blueberry polyphenols, after a certain 
time of ingestion, and at a certain dosage. One possible explanation is that participants may have 
become habituated to the effect of the blueberry intervention with less cognitive benefit being 
evident at later stages of treatment. Furthermore, Whyte et al. (41) consider the possibility of 
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practice effects whereby the performance of each of participant improves over time reducing the 
early advantage of blueberry intervention.  Nevertheless, the lack of chronic data, plus the limited 
range of different cognitive domains within chronic studies tested are not enough for any conclusive 
points to be made here.  
In the papers studied, the anthocyanin content ranged from 1.35 mg (41) to 460 mg . However, 
higher anthocyanin concentration does not necessarily translate to better cognition compared to 
lower doses suggesting that a ceiling effect is likely, with higher doses producing no extra benefits. 
This would seem to correlate with physiological responses to blueberry intervention such as flow 
mediated dilation (FMD) which can be seen to peak following doses containing 766 mg anthocyanin 
and tail off at higher doses (10). It is believed that this improvement in endothelial function is a nitric 
oxide (NO) mediated response exerted by polyphenolic compounds found in blueberries.  
Currently only two studies involving blueberries have investigated the effects of cerebral blood flow 
(CBF) where an increase in cerebral blood flow to the brain was found after acute (19) and chronic 
(40) blueberry treatment when compared to placebo. This suggests one mechanism by which 
blueberries may be exerting a positive effect on cognition. Other studies involving flavonoids and 
CBF have shown a similar effect, with an increase in CBF observed after an acute intake of citrus 
juice high in flavanones (47) or cocoa flavanols (48). This raises the question whether improved 
endothelial function might facilitate an increase in peripheral blood flow, and thus cerebral blood 
flow, which in turn may improve cognitive functioning. This is an area which still requires extensive 
research. Further details of studies which have considered the effects of polyphenol intervention on 
cardiovascular health and cerebrovascular health can be found in other reviews (for example see this 
recent review (49)).  
In terms of the interventions themselves, there is a large variation in the actual anthocyanin content 
of the treatments.  The flavonoid ratio in equivalent weights of the blueberry treatments also 
differed between studies, for example, 30g of freeze-dried blueberry powder contained 253 mg of 
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anthocyanins in Whyte et al. (28) whereas the equivalent fresh contained 148 mg in Whyte and 
Williams (27). This highlights the importance of analysing blueberry powder for 
polyphenol/anthocyanin content prior to starting an intervention.  
In terms of study design, all but two studies (39, 45) employed a double-blind crossover, placebo-
controlled design, which seems the most appropriate design when comparing a nutritional 
intervention against placebo. In most cases the blueberry was administered as a freeze-dried 
powder mixed with water and administered as a drink. Only one study mixed the powder with milk 
(27). Nevertheless, the evidence currently available related to the inhibition of polyphenols by dairy 
proteins is equivocal. Some studies demonstrate that proteins found in milk have no effect on the 
bioavailability of polyphenols (50) and some believe that it may affect the bioavailability of some, 
but not all, polyphenolic compounds (51). Ultimately it should be taken into consideration that 
factors other than dairy proteins may also play a role in the absorption and metabolism of 
polyphenols, including the gut microbiota and the chemical structure of the polyphenol (e.g hydroxyl 
group have a high affinity for proteins) amongst other dietary factors (52).    
In conclusion, the cognitive research considering blueberry intervention currently gives an 
incomplete picture, with no published research as yet having considered infants, teens, young 
adults, or middle-aged adults. Acute effects have only been considered in children and chronic 
effects have only been considered in older adults. Findings from the present literature indicate that 
benefits might be found in most reliably in episodic memory and, under certain conditions, executive 
function, with the benefits for working memory at present being more equivocal. More specifically, 
there is a trend where improvements are seen within the executive function and episodic memory 
domains for children; for adults there are more memory related improvements and in adults with 
MCI improvements are found primarily within the episodic memory domain. Therefore, the current 
literature indicates that blueberry polyphenols have the capacity to improve some aspects of 
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cognition across certain ages, and with further investigation, is a concept which might be applied to 
specific real-life situations such as learning.  
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 Table 1. Comparison of anthocyanidin content (mg/100g FW) in different berries retrieved from USDA Database for the Flavonoid Content of Selected Foods Release 3.1 
(2014) 
 
Flavonoid subclass 
Content of flavonoids in some common berries (raw form) (mg/100g of fresh weight) 
 Blueberries (highbush) Blackberries Blackcurrant Chokeberry Grapes Raspberries Strawberries 
Anthocyanidins        
Cyanidin 8.46 99.5 62.46 344.07 1.16 45.77 1.68 
Delphinidin 35.43 0.00 89.62 0.65 2.27 1.32 0.31 
Malvidin 67.59 0.00 n/a 1.22 39.00 0.13 0.01 
Pelargonidin 0.00 0.45 1.17 0.98 0.02 0.98 24.85 
Peonidin 20.29 0.21 0.66 0.08 3.62 0.12 0.05 
Petunidin 31.53 0.00 3.87 2.79 1.97 0.31 0.11 
Total 163.3 100.16 157.78 349.79 48.04 48.63 27.01 
Flavan-3-ols        
(-)-Epicatechin 0.62 4.66 0.47 n/a 0.96 3.52 0.42 
(-)-Epicatechin 3-gallate 0.00 0.00 0.00 n/a 0.17 0.00 0.15 
(-)-Epigallocatechin 0.66 0.10 0.00 n/a 0.08 0.46 0.78 
(-)-Epigallocatechin 3-gallate 0.00 0.68 0.00 n/a 0.00 0.54 0.11 
(+)-Catechin 5.29 37.06 0.70 n/a 0.82 1.31 3.11 
(+)-Gallocatechin 0.12 0.00 0.00 n/a 0.00 0.00 0.03 
Total 6.69 42.5 1.17 n/a 2.03 5.83 4.6 
Flavonones        
Hesperetin 0.00 0.00 n/a n/a n/a 0.00 0.00 
Naringenin 0.00 0.00 n/a n/a n/a 0.00 0.26 
Total 0.00 0.00 n/a n/a n/a 0.00 0.26 
Flavones        
Apigenin 0.00 0.00 0.00 n/a 0.00 0.00 0.00 
Luteolin 0.20 0.00 0.00 n/a 1.30 0.00 0.00 
Total 0.20 n/a 0.00 n/a 1.30 0.00 0.26 
Flavonols        
Isorhamnetin n/a n/a 0.12 n/a n/a 0.00 0.00 
Kaempferol 1.66 0.27 0.71 0.34 0.00 0.06 0.50 
Myricetin 1.30 0.67 6.18 0.00 0.01 0.00 0.04 
Quercetin 7.67 3.58 4.45 18.53 1.04 1.05 1.11 
Total 10.63 4.52 11.46 18.87 1.05 1.11 1.65 
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Note. BB = Blueberry, FE = Fresh Equivalent; EM = Episodic Memory, EF = Executive Function, WM = Working Memory, PF = Psychomotor Function. 
Author(s) Treatme
nt 
Total 
Anthocya
nin (mg) 
Total 
Polyphe
nol (mg) 
Study design Study 
type 
Measurement 
time points 
Size 
(n) 
Age 
range 
(years
) 
Cognitive tests (cognitive 
domain tested in 
parenthesis) 
Key findings  Effect size (Cohen’s d) 
Whyte & 
Williams 
(2015)(27) 
200g 
fresh BB 
143 
 
N/A Double blind, 
placebo-
controlled 
crossover 
design 
Acute 2 hrs 14 8-10 (1) Go-NoGo (EF) 
(2) Stroop (EF) 
(3) Rey's Auditory Verbal 
Learning Task (AVLT) (EM) 
(4) Object Location Task 
(EM) 
(5) Visual N-back (WM) 
AVLT: Delayed Recall 
• BB vs Placebo  (p= .038) 
 
AVLT: Proactive Interference 
• BB vs Placebo (p= .043*) 
 
*Better placebo performance. 
  
0.904 
 
 
0.883 
Whyte, 
Schafer & 
Williams 
(2016)(28) 
Freeze 
dried BB 
powder  
(1) 15 g 
(120 g 
FE) (2) 
30g (240 
g FE) 
(1) 127 
(2) 253 
N/A Double blind, 
placebo-
controlled 
crossover 
design 
Acute 1.15, 3, & 6 
hrs 
21 8-10 (1) Auditory-Verbal 
Learning Task (EM)  
(2) Modified Flanker Task 
(MFT) (EF)  
(3) Go-NoGo (EF) 
(4) Picture Matching Task 
(PMT) (EF) 
AVLT: Final Acquisition at 1.15hr 
 30g BB vs Placebo (p=.023) 
 
AVLT: Delayed Word  
Recognition at 6hrs 
 15g BB vs Placebo (p=.038) 
 
MFT: Incongruent Trial Accuracy at 
3hrs  
 BB vs Placebo (p=.035) 
  
0.908*** 
 
 
 
0.245 
 
 
 
0.201 
Whyte, 
Schafer & 
Williams 
(2017)(29) 
Freeze 
dried BB 
powder, 
30g (240 
g FE) 
253 N/A Double blind, 
placebo-
controlled 
crossover 
design 
Acute 
 
3 hrs 21 7-10 (1) Modified Attention 
Network Task (MANT) (EF) 
MANT: Reaction Time 
 BB  vs Placebo (p = .048) 
 0.940*** 
Barfoot et 
al (2018) 
Freeze 
dried BB 
powder, 
30g (240 
g FE) 
253 N/A Randomised, 
single-blind, 
parallel-
groups design 
Acute 2 hrs 54 7-10 (1) Rey's Auditory-Verbal 
Learning Task (EM)  
(2) Modified Attention 
Network Task (MANT) (EF) 
(3) Test of Word Reading 
Efficiency-2; TOWRE-2 
(reading efficiency) 
 
AVLT: Total acquisition 
performance  
 BB vs Placebo  (p= 0.035) 
 
AVLT:  Short delay recall  
 BB vs Placebo (p=0.04)  
 
MANT: Reaction time 
 BB vs Placebo  (p=0.018). 
 
  
 
0.425 
 
 
0.405 
 
 
0.175 
Table 2: Key studies investigating the effects of blueberry supplementation on cognition in healthy children. 
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Author(s) Treatment and 
amount 
Total 
Anthocyanin 
(mg) 
Total 
Polyphenol 
(mg) 
 Study 
design 
Study 
type 
Measurement 
time points 
Size 
(n) 
Age 
range 
(years) 
Cognitive tests (cognitive 
domain tested in 
parenthesis) 
Key findings Effect size 
(Cohen’s d) 
Schrager et 
al. 
(2015)(36) 
Frozen BB - 2 
cups daily 
(approx. 300g 
FE). 
N/A N/A  Placebo 
controlled, 
parallel 
design.  
Randomisati
on and 
blinding not 
stated.  
Chronic  Baseline and 
week 6 
20 61-80 (1) Simple Reaction Time (PF) 
(2) Trail Making Test part B 
(EF) 
(3) Dual-Task adaptive gait 
test (DTAG) (EF/PF)  
DTAG: Step Errors 
 BB vs Placebo (p = 
.048)  
 
1.16** 
Miller et al . 
(2017)(35)  
Freeze dried BB 
powder, 24g 
(approx. 150g 
FE) 
460  864  Double-
blind, 
placebo-
controlled, 
parallel 
design 
Chronic  Baseline, day 
45 and day 
90. 
37 60-75 (1) Task-switching test (TST) 
(EF) 
(2) Trail-making test (TMT) 
(EF) 
(3) California Verbal Learning 
Test. CVLT-II) (EM) 
(4) Digit span task (DS) (WM) 
(5) Virtual Morris Water 
Maze (vMWM) (WM) 
(6) Attention Network Task 
(ANT) (WM) 
TST: Switch Cost 
 BB improvement 
across visits (p = 
.033) 
 
CVLT: Repetition Errors 
 BB improvement 
across visits (p = 
.031) 
 
0.629*** 
 
 
0.759*** 
Bowtell et 
al. 
(2017)(40) 
BB concentrate, 
30ml (FE N/A) 
387  N/A  Double 
blind, 
placebo-
controlled 
crossover 
design 
Chronic  Baseline and 
week 12 
26 60-75 (1) Detection task (PF) 
(2) Groton maze timed chase 
test (EF) 
(3) Groton maze learning test 
(EF) 
(4) identification task (EF) 
(5) International shopping list 
task (EM)  
(6) 1-back and 2-back 
memory tasks (WM) 
2-back task 
 BB vs Placebo (p = 
.05 trend) 
 
fMRI: Brain activity 
 BB vs Placebo (p < 
.001) 
n/a 
 
           Table 3: Key studies investigating the effects of blueberry supplementation on cognition in healthy adults. 
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Note. BB = Blueberry, FE = Fresh Equivalent; EM = Episodic Memory, EF = Executive Function, WM = Working Memory, PF = Psychomotor Function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Whyte et 
al.  
(2018)(41) 
 
 
 
 (1) 500 mg 
Wild BB Powder 
(WBP500) 
(2) 1000 mg 
Wild BB Powder 
(WBP1000) 
(3) 111 mg Wild 
BB Extract 
(WBE111) 
(1) 1.35 
(2) 2.7 
(3) 7 
(1) 35 
(2) 70 
(3) 50 
 Double 
blinded, 
placebo-
controlled 
parallel 
design 
Chronic Baseline, 
week 12 and 
week 24 
112 65–80 (1)  RAVLT (EM) 
(2)  Object recognition task 
(EM) 
(3)  Corsi Blocks task (EM) 
(4)  Serial subtractions tasks 
(WM) 
(5)  The Sternberg memory 
scanning task (WM) 
(6)  Modified Attention 
Network Task (EF) 
(7) Stroop (EF) 
RAVLT: Word 
Recognition at 12 
weeks 
 WBE111 vs 
Placebo (p = .038) 
 
Corsi Blocks: Total 
Sequences 
 WBE111 vs 
Placebo (p = .069 
trend) 
 
 
0.578 
 
0.289 
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Author(s) Treatment Total 
Anthocyanin 
(mg) 
Total 
Polyphenol 
(mg) 
Study 
design 
Study 
type 
Measurement 
time points 
Size (n) Age range (years) Cognitive tests 
(cognitive 
domain tested in 
parenthesis) 
Key findings Effect size 
(Cohen’s d) 
Krikorian et 
al . 
(2010)(33) 
Wild BB juice. 
By participant 
weight: 
(1) 54-64 kg = 444 
ml 
(2) 65–76 kg = 
532 ml 
(3) 77–91 kg = 
621 ml 
(FE N/A) 
(1) 428 
(2) 512 
(3) 598 
(1) 1056 
(2) 1266 
(3) 1478 
Double 
blind, 
placebo-
controlled 
crossover 
design 
Chronic  Baseline and at 
12 weeks 
9 Mean age: 72 (1) California 
Verbal Learning 
Test (CVLT) (EM) 
(2) Verbal paired 
associate 
learning test (V-
PAL) (EM)   
V-PAL: Cumulative 
Learning 
 BB 
improvement 
across visits (p 
= .009) 
 BB vs Placebo 
(p = .03) 
CVLT: Word Recall 
 BB 
improvement 
across visits (p 
= .04) 
 
 
1.78* 
 
 
0.96** 
 
1.18* 
Boespflug et 
al . 
(2017)(32) 
25 g Freeze-dried 
BB powder 
(approx. 150g FE) 
269 417  Double 
blind, 
placebo-
controlled 
crossover 
design 
Chronic  Baseline and at 
16 Weeks 
16 68 –92 (1) n-back WM 
task (WM) 
No sig. effects after 
16 weeks of 
supplementation. 
fMRI: Brain activity 
 BB relative to 
baseline  (p < 
.01) 
 
 
1.82 (left 
inferior 
parietal 
gyrus) and 
1.94 (left 
pre-central 
gyrus) 
Table 4: Key studies investigating the effects of blueberry supplementation on cognition in adults with MCI. 
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Note. BB = Blueberry, FE = Fresh Equivalent; EM = Episodic Memory, EF = Executive Function, WM = Working Memory, PF = Psychomotor Function 
 
*= Effect sizes reported from article (Cohen’s d) 
**= Effect sizes originally reported from article as Cohen’s f, and converted to Cohen’s d for the purpose of this review. 
***=Effects sizes originally reported as partial ETA square and converted to Cohen’s d for the purpose of this review. 
 
 
 
 
 
 
McNamara 
et al . 
(2018)(34)  
25 g Freeze-dried 
BB powder 
(approx. 150g FE) 
269 417 Double 
blind, 
placebo-
controlled 
crossover 
design 
Chronic  Baseline and at 
24 Weeks 
19 62-80 (1) Dysexecutive 
Questionnaire (D
EX) (EF/WM) 
(2) Trail making 
test A and Trail 
making test B 
(EF)  
(3) Controlled 
Oral Word 
Production (EF)  
4) Hopkins 
Verbal Learning 
Test (HVLT) (EM)  
DEX: Cognitive 
Symptoms 
 BB vs Placebo 
(p = .05) 
 
HVLT: Memory 
Discrimination 
 BB vs Placebo 
(p = .04) 
 
  
 
 
0.68** 
 
 
 
 
0.68** 
